Serious: Pfizer has hidden that one of his drugs could prevent Alzheimer's disease

The Washington Post revealed that Pfizer had been hiding for years that its rheumatoid arthritis medications were also used to prevent the risk of Alzheimer's disease by nearly 64%.

In 2015, as a result of the symptoms of a group of patients, a group of Pfizer researchers discovered that this drug had serious effects on the brain, but did not want to delve into this issue for not spending 80 million dollars.

But the company's own researchers put pressure on the multinational laboratory so that thousands of patients could be studied in a clinical trial to determine if Enbrel was able to delay Alzheimer's disease.

The pharmaceutical company explained to The Washington Post that between 2015 and 2018, this issue was discussed because it was not certain that Enbrel could successfully fight against Alzheimer's disease because it does not happen directly on brain tissue. Pfizer argued that the available data did not meet their expectations. "rigorous scientific standards" and therefore, he questioned the results.

The spokesman of the company, Ed Harnagahe excused, saying that "The revelation of the data could have opened the wrong window for researchers around the world."

This claim has been rejected by scientists outside the company worldwide because, being an Alzheimer's disease without apparent cure, without prevention or treatment, the data could have allowed millions of researchers to find a cure. 39 to help patients who are suffering from this terrible degenerative disease.

"Of course, they should have published it. Why not?"says in the American journal Rudolph E. Tanzi, a researcher of the disease and a professor at Harvard Medical School. These are important clues in the stalemate of Alzheimer's disease.

Pfizer has continued to excuse its scientific reasons, but at least now, there is a global knowledge of what this drug can do, which will give researchers the tissue to cut and a door on a possible prevention of disease. Alzheimer.